chr9-95506496-AAGAACTTGCCGCAGTTTTTTTGAATGTAACAACCC-A
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1PP5_Moderate
The NM_000264.5(PTCH1):c.270_304delGGGTTGTTACATTCAAAAAAACTGCGGCAAGTTCT(p.Tyr93GlyfsTer35) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. L90L) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000264.5 frameshift
Scores
Clinical Significance
Conservation
Publications
- basal cell nevus syndrome 1Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
- holoprosencephaly 7Inheritance: AD Classification: DEFINITIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- nevoid basal cell carcinoma syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- holoprosencephalyInheritance: AD Classification: LIMITED Submitted by: Illumina
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PTCH1 | NM_000264.5 | c.270_304delGGGTTGTTACATTCAAAAAAACTGCGGCAAGTTCT | p.Tyr93GlyfsTer35 | frameshift_variant | Exon 2 of 24 | ENST00000331920.11 | NP_000255.2 | |
| PTCH1 | NM_001083603.3 | c.267_301delGGGTTGTTACATTCAAAAAAACTGCGGCAAGTTCT | p.Tyr92GlyfsTer35 | frameshift_variant | Exon 2 of 24 | ENST00000437951.6 | NP_001077072.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PTCH1 | ENST00000331920.11 | c.270_304delGGGTTGTTACATTCAAAAAAACTGCGGCAAGTTCT | p.Tyr93GlyfsTer35 | frameshift_variant | Exon 2 of 24 | 5 | NM_000264.5 | ENSP00000332353.6 | ||
| PTCH1 | ENST00000437951.6 | c.267_301delGGGTTGTTACATTCAAAAAAACTGCGGCAAGTTCT | p.Tyr92GlyfsTer35 | frameshift_variant | Exon 2 of 24 | 5 | NM_001083603.3 | ENSP00000389744.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Gorlin syndrome Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. While this particular variant has not been reported in the literature, truncating variants in PTCH1 are known to be pathogenic (PMID: 16301862, 16419085). This sequence change deletes 35 nucleotides from exon 2 of the PTCH1 mRNA (c.270_304del), causing a frameshift at codon 93. This creates a premature translational stop signal (p.Tyr93Glyfs*35) and is expected to result in an absent or disrupted protein product. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at